Drug intelligence / Profile preview

cinchonidine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intramuscular, Intravenous
01

Overview

Cinchonidine is a natural alkaloid found in the bark of Cinchona officinalis and Gongronema latifolium. It is a stereoisomer of cinchonine and is structurally related to other Cinchona alkaloids such as quinine and quinidine. Historically, cinchonidine has been used as an antimalarial agent, particularly for malaria caused by Plasmodium falciparum, often as part of combination therapies like Quinimax. In addition to its antimalarial properties, cinchonidine serves important roles in pharmaceutical development as an intermediate in the synthesis of various drugs and as a chiral ligand in asymmetric synthesis for producing enantiomerically pure compounds. Recent research suggests that it may alleviate cisplatin-induced ototoxicity by regulating PI3K-AKT signaling pathways[8]. Its mechanism of action against malaria is presumed similar to other Cinchona alkaloids—interfering with heme detoxification within the parasite—but specific molecular targets are not fully characterized[1][3][5][8].

Brand names
Quinimax
Other names
alpha-quinidinecinchovatinequinine bisulfate impurity Bquinine hydrochloride impurity Bquinine sulfate impurity B
02

Targets

CALR (Calreticulin)Heme

Beyond the preview

Go deeper on cinchonidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cinchonidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call